Prognosis
Canada Halts AstraZeneca Shots for Under 55 on Clot Concerns
- Europe evidence of rare side effect prompts vaccine pause
- With cases rising, B.C. also shuts restaurants, gyms, churches
A healthcare worker administers a Covid-19 vaccine at a Vancouver clinic on March 4.
Photographer: Jennifer Gauthier/BloombergThis article is for subscribers only.
Health officials in Canada are suspending plans to give AstraZeneca Plc’s Covid-19 vaccine to younger people over concerns it could lead to blood clots in rare circumstances.
Provincial health authorities, including those in Ontario, Quebec, British Columbia and Alberta, halted the AstraZeneca shots after the nation’s vaccine advisory committee recommended a pause on administering it to people under 55 years old.